Clinical Trial Update: Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing neoadjuvant PROSTVAC-VF with or without ipilimumab in prostate cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostatic Neoplasms

Drugs mentioned

• PROSTVAC-VF (PROSTVAC-VF)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Lawrence Fong | Conditions: Prostatic Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2021-11-24